ReviewInternational journal of molecular sciences2026
Bone and Infections: An Osteoimmunological Interplay.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metformin as a Metabolic Reprogramming Interface in Host-Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss.Antibiotics (Basel, Switzerland) · 2026Review
- Clinical Outcome After Surgery for Fracture-Related Infection Is Dependent on Both Microbiology and the Host Inflammatory Response.Pathogens (Basel, Switzerland) · 2026Article
- Context-dependent roles of the NLRP3 inflammasome in osteomyelitis and strategies for precision modulation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteoimmunology examines the bidirectional interactions between the skeletal and immune systems, focusing on the mechanisms by which immune cells regulate bone homeostasis and how the bone microenvironment modulates immune responses. Chronic inflammation is a major driver of bone loss, and infections of bacterial or viral origin perturb bone remodeling with consequences for host defense. In infected bone tissue, immune cell infiltration and the release of cytokines and soluble mediators alter the activity of osteoclasts and osteoblasts, thereby promoting bone erosion and structural remodeling. Recent studies highlight how immune dysregulation contributes to the pathogenesis of osteomyelitis and other infection-associated bone disorders, implicating specific inflammatory pathways and cellular interactions as potential therapeutic targets. This review synthesizes current evidence on direct and indirect mechanisms by which infection affects bone, identifies gaps in mechanistic understanding, and discusses implications for diagnosis and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.